Skip to Content
Tell us what you think: The PAPAA Forum

The PAPAA Forum: Psoriasis, Dr David Ashton, Nov 2020

Systemic drug therapy in the obese patient with psoriasis

Should a patient’s Body Mass Index (BMI) influence the choice of a systemic drug in the treatment of psoriasis and psoriatic arthritis?  A recent report suggests that the answer is ‘Yes’1.

There is a strong and consistent association between obesity and psoriasis; obese patients are more likely to develop psoriasis and its severity increases with…